COMPUTERIZED EEG TOPOGRAPHY FINDINGS IN SCHIZOPHRENIC-PATIENTS BEFORE AND AFTER HALOPERIDOL TREATMENT

被引:33
作者
KEMALI, D [1 ]
GALDERISI, S [1 ]
MAJ, M [1 ]
MUCCI, A [1 ]
DIGREGORIO, M [1 ]
BUCCI, P [1 ]
机构
[1] NAPLES UNIV,SCH MED 1,DEPT PSYCHIAT,I-80138 NAPLES,ITALY
关键词
COMPUTERIZED EEG TOPOGRAPHY (CET); SCHIZOPHRENIA; HALOPERIDOL TREATMENT;
D O I
10.1016/0167-8760(92)90078-P
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
An increase of delta and fast beta activity in schizophrenic patients when compared with normal controls has been consistently reported. Topography of these abnormalities, in particular a possible frontal localization of delta, and their relationship to drug treatment and clinical status are still debated. In order to assess these issues, a multilead CEEG investigation was carried out in a group of 20 DSM-III-R schizophrenics, both before and after haloperidol treatment. All findings are described in terms of amplitude and relative power. Drug-free schizophrenics, when compared with a group of normal controls, showed a generalized increase of delta and fast beta, and a decrease of alpha2 relative power. After acute treatment, patients showed a significant decrease of delta, and an increase of theta2, beta1, and beta2. After 28 days of haloperidol treatment, similar changes were observed for delta, together with an increase of alpha1, and a decrease of fast beta.
引用
收藏
页码:283 / 290
页数:8
相关论文
共 29 条
[1]  
ABT K, 1988, STAT TOPOGRAPHY QUAN, P150
[2]  
Andreasen N.C., 1981, SCALE ASSESSMENT NEG
[3]  
[Anonymous], 1984, SCALE ASSESSMENT POS
[4]  
ASBERG M, 1978, ACTA PSYCHIATR SCA S, V271
[5]   GLUCOSE METABOLIC-RATE IN NORMALS AND SCHIZOPHRENICS DURING THE CONTINUOUS PERFORMANCE-TEST ASSESSED BY POSITRON EMISSION TOMOGRAPHY [J].
BUCHSBAUM, MS ;
NUECHTERLEIN, KH ;
HAIER, RJ ;
WU, J ;
SICOTTE, N ;
HAZLETT, E ;
ASARNOW, R ;
POTKIN, S ;
GUICH, S .
BRITISH JOURNAL OF PSYCHIATRY, 1990, 156 :216-227
[6]  
BUCHSBAUM MS, 1982, ARCH GEN PSYCHIAT, V39, P251
[7]   NEW METHODS TO DETERMINE THE CNS EFFECTS OF ANTIGERIATRIC COMPOUNDS - EEG TOPOGRAPHY AND GLUCOSE USE [J].
BUCHSBAUM, MS ;
CAPPELLETTI, J ;
COPPOLA, R ;
REGAL, F ;
KING, AC ;
VANKAMMEN, DP .
DRUG DEVELOPMENT RESEARCH, 1982, 2 (05) :489-496
[8]  
FARKAS T, 1984, ARCH GEN PSYCHIAT, V41, P293
[9]  
Galderisi S, 1990, Eur Neuropsychopharmacol, V1, P51, DOI 10.1016/0924-977X(90)90011-X
[10]  
GALDERISI S, 1992, SCHIZOPHR RES, V6, P15